Skip to main content
. 2008 May 28;3(5):e2303. doi: 10.1371/journal.pone.0002303

Table 1. Cell Cycle analysis of SKOV-3 after Fe-SP treatment.

Fe-SP SP Ctr.
Sub- Sub-
G0/G1 S G2/M G0/G1 G0/G1 S G2/M G0/G1
[%] [%] [%] [%] [%] [%] [%] [%]
No Drug 75.0 22.1 2.9 1.2 72.5 24.0 3.5 1.2
24 h 0.4 µM 73.8 19.4 6.9 7.2 73.8 20.9 5.3 0.8
0.8 µM 44.7 28.0 13.9 5.8 71.2 22.9 5.9 3.9
1.6 µM 24.6 75.4 0 16.7 72.2 21.7 6.1 0.5
No Drug 74.4 16.5 9.0 0.3 71.6 17.8 10.7 0.3
48 h 0.4 µM 65.5 22.3 12.3 9.8 68.9 19.8 11.3 0.7
0.8 µM 43.3 40.9 16.3 17.3 70.0 18.4 11.6 1.5
1.6 µM 12.9 87.1 0 15.8 73.0 16.4 10.6 1.0

Cell cycle analysis was carried out as described (Materials and Methods). SKOV-3 cells were treated with 0, 0.4, 0.8 and 1.6 µM Fe-SP or SP (Ctr.) for 24 or 48 h. Data were obtained by FACS analysis based on propidium-iodide intercalation into cellular chromatin.